Burnham Institute for Medical Research Executive Vice President, Dr. Gary F. Raisl, Assumes Chief Financial Officer Duties

Released: 12/7/2009 1:15 PM EST
Source Newsroom: Sanford-Burnham Medical Research Institute
Contact Information

Available for logged-in reporters only

Newswise — Burnham Institute for Medical Research (Burnham) has appointed Executive Vice President Gary F. Raisl, Ed.D., to the position of Chief Financial Officer. In this role, Dr. Raisl will provide strategic direction and oversee the day-to-day financial operations of Burnham’s California and Florida campuses. This consolidation of financial leadership will streamline operations and reporting. Dr. Raisl is currently Burnham’s Chief Administrative Officer and treasurer.

”Dr Raisl has been an outstanding addition to the Burnham team,” said John Reed, M.D., Ph.D., Burnham’s President and CEO, professor and Donald Bren Presidential Chair. “In particular, his expertise enabled Burnham to successfully negotiate the purchase of the former Sidney Kimmel Cancer Center property and has ensured that Burnham has the capacity to expand our scientific endeavors.”

Dr. Raisl has more than 25 years experience leading complex non-profit educational and research institutions. Prior to joining Burnham in March 2009, he was vice president for finance and administration for the Institute for Systems Biology in Seattle, Washington. Prior to that, Dr. Raisl served as vice president for finance and administration and treasurer at the University of the Sciences, Neumann College and St. Gabriel’s systems in Philadelphia, Pennsylvania. Dr. Raisl began his career in finance and administration at the City University of New York and Bronx Community College.

Dr. Raisl received his B.A. with honors from the University of Notre Dame; his M.A. and M.Phil., degrees from Columbia University; his M.B.A. from Widener University and his doctorate in higher education management from the University of Pennsylvania. He has also studied at Harvard University’s School of Education, Harvard Business School, Yale University’s School of Management and Massachusetts Institute of Technology.

“Burnham is a dynamic, thriving organization. I am gratified that I can contribute to the overall success of the organization,” said Dr. Raisl.

About Burnham Institute for Medical Research

Burnham Institute for Medical Research is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Burnham, with operations in California and Florida, is one of the fastest-growing research institutes in the country. The institute ranks among the top four institutions nationally for NIH grant funding and among the top organizations worldwide for its research impact. For the past decade (1999-2009), Burnham ranked first worldwide in the fields of biology and biochemistry for the impact of its research publications (defined by citations per publication), according to the Institute for Scientific Information.

Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Burnham is a nonprofit public benefit corporation.


Comment/Share